Sandoz Group AG (Sandoz Group AG) Total Assets : $19,430 Mil (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Sandoz Group AG Total Assets?

Sandoz Group AG's Total Assets for the quarter that ended in Dec. 2023 was $19,430 Mil.

During the past 12 months, Sandoz Group AG's average Total Assets Growth Rate was -2.70% per year.

Total Assets is connected with ROA %. Sandoz Group AG's annualized ROA % for the quarter that ended in Dec. 2023 was 1.67%. Total Assets is also linked to Revenue through Asset Turnover. Sandoz Group AG's Asset Turnover for the quarter that ended in Dec. 2023 was 0.54.

Sandoz Group AG Total Assets Historical Data

The historical data trend for Sandoz Group AG's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sandoz Group AG Total Assets Chart

Sandoz Group AG Annual Data

Trend

Dec22

Dec23

Total Assets

17,557.00

19,430.00

Sandoz Group AG Quarterly Data
	Dec22	Dec23
Total Assets	17,557.00	19,430.00

Sandoz Group AG Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Sandoz Group AG's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	8654	+	10776
	=	19,430

Sandoz Group AG's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2023 )	+	Total Liabilities (Q: Dec. 2023 )
	=	8654	+	10776
	=	19,430

Sandoz Group AG (OTCPK:SDZNY) Total Assets Explanation

Total Assets is connected with ROA %.

Sandoz Group AG's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %	=	Net Income (Q: Dec. 2023 )	/	( (Total Assets (Q: Dec. 2022 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	308	/	( (17557	+	19430)	/ 2 )
	=	308	/	18493.5
	=	1.67 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Sandoz Group AG's Asset Turnover for the quarter that ended in Dec. 2023 is

	Asset Turnover
=	Revenue (Q: Dec. 2023 )	/	( (Total Assets (Q: Dec. 2022 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
=	9979	/	( (17557	+	19430)	/ 2 )
=	9979	/	18493.5
=	0.54

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Sandoz Group AG Total Assets Related Terms

Thank you for viewing the detailed overview of Sandoz Group AG's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Sandoz Group AG (Sandoz Group AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sandoz Group AG (OTCPK:SDZNY) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

SDZXF:USA SDZz:UK D8Y0:Germany SDZ:Switzerland

Address

Forum 1, Novartis Campus, Basel, CHE, CH-4056

Website

https://www.sandoz.com

Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $9 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules and complex injectables, make up roughly 75% of Sandoz's total sales, and the firm has a significant presence in Europe, the United States, and other key international markets. Sandoz generates its remaining sales from biosimilars and is among leaders in the space. Sandoz launched Europe's first biosimilar, Omnitrope, in 2006 as well as U.S.'s first biosimilar, Zarxio, in 2015. It currently has eight commercialized biosimilars in a number of markets and has over 20 assets in pipeline.

Sandoz Group AG (Sandoz Group AG) Headlines

From GuruFocus

Q3 2023 Sandoz Group AG Earnings Call Transcript

By GuruFocus Research • 02-14-2024

Q3 2023 Sandoz Group AG Earnings Call Transcript

By GuruFocus Research • 02-14-2024